Warning Letter Roundup & Recap – Oct. 24, 2017
Executive Summary
US FDA outlined quality systems and Medical Device Reporting troubles in three device-related warning letters this week, including one addressed to Magellan Diagnostics for ongoing regulatory issues. A fourth letter dinged a firm for failing to have pre-market clearance for its products.